NCT04541420View on ClinicalTrials.gov

Eribulin in mTNBC Patients

CompletedOBSERVATIONAL

Enrollment

208

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

December 15, 2020

Study Completion Date

December 20, 2020

Conditions

Breast Cancer

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER

NCT04541420 - Eribulin in mTNBC Patients | Biotech Hunter | Biotech Hunter